Ultralife Corporation Reports Second Quarter Results

Ultralife Corporation (NASDAQ: ULBI) reported Q2 2026 results for the quarter ended June 30. Sales fell to $47.9 million from $48.6 million in Q2 2025. Gross profit rose to $13.9 million, with gross margin 28.9%. GAAP EPS was $0.15 vs $0.05, and adjusted EBITDA was $6.1 million vs $4.1 million. Backlog rose to $117.5 million.

Original reporting
Published Aug 7, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 11:46 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ULBI
Bullish
medium confidence
Mentioned
$ULBI
Relevance
9/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

Q2 results show YoY revenue down slightly, but profitability improved materially: gross margin rose to 28.9% (26.6% excluding the IEEPA refund), GAAP EPS increased to $0.15, and adjusted EBITDA rose to $6.1M. Backlog reached $117.5M, the highest in company history, which can support future production and revenue conversion.

02

Market read

Traders can reassess ULBI’s earnings trajectory using the fresh margin, EPS, adjusted EBITDA, and record backlog figures, plus segment-level growth and cost drivers.

03

What to watch

Operating expenses rose due to new product development and one-time litigation/consulting costs, so investors may need to separate sustainable margin gains from temporary cost and tariff effects.

Relevance 9/10Novelty 8/10Timing: earnings release and conference call today (Aug 7, 2026)

Background

Ultralife operates two segments, Battery & Energy Products and Communications Systems, and is executing manufacturing-efficiency initiatives plus new product development for government/defense programs.

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

Ultralife reported Q2 revenue of $47.9M, GAAP EPS $0.15, and gross margin up to 28.9% with backlog hitting a record $117.5M.

Expected impact

Likely positive bias for ULBI on earnings-day positioning, with follow-through dependent on whether investors focus on margin quality and backlog conversion.

Evidence & confidence

The release provides multiple fresh datapoints (GAAP EPS, gross margin ex-refund, adjusted EBITDA, and record backlog) that can re-rate expectations, though the top-line decline tempers the signal.

Market effects

Signals improving profitability in defense-linked communications and battery systems, potentially supportive for small-cap defense electronics sentiment.

Limited direct regional spillover; primarily company-specific.

References government/defense programs and international operations, but no new global macro or policy shock beyond tariff/refund context.

Counterpoint

Gross margin improvement is partly attributed to a net IEEPA refund; if that benefit is non-recurring, the earnings power may be overstated.

Key entities

  • Ultralife Corporation

    NASDAQ-listed company reporting Q2 2026 results, margin improvement initiatives, and record backlog.

  • Communications Systems segment

    Reported 39.3% YoY revenue growth to $3.8M and higher gross margin driven by sales mix.

  • Battery & Energy Products segment

    Reported revenue decline to $44.2M but improved gross margin to 28.3% aided by favorable mix and IEEPA refund.

Related articles

$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

$ULBIMed

Ultralife Corporation Reports Second Quarter Results

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil

$NKEHighAI 8/10

Analyst warns Nike's best quarter this year may be behind it

Nike (NKE) reported Q1 earnings beating estimates, but investors sold shares. Morgan Stanley warns this may be the best quarter of the year, citing inventory risks and weaker forecasts. Nike expects fiscal 2027 revenue to decline by a high single-digit percentage. Analysts cut price targets, with Morgan Stanley suggesting a 50% drop in EPS over the next three quarters.

$CCLHighAI 8/10

Carnival (CCL) Reports Strong Q3 Earnings, Dividend Sustainabili

Carnival Corporation (CCL) reported Q3 earnings of $1.43 per share, beating estimates by $0.08. The company offers a 1.56% dividend yield with a 19% payout ratio, and its stock is fairly valued at $25.76. CCL has a GF Score of 76, reflecting strengths in profitability and valuation but weaknesses in financial strength. Institutional investors show mixed sentiment, with 9 gurus increasing positions and 4 trimming them, while insiders sold $13.5 million in shares over the past year.

$MUMedAI 8/10

Micron Just Extended Its Forecast for the AI Build-Out to 2031. Its Stock Is Bound to Defy History.

Micron Technology updated its forecast, stating that customer demand for memory chips will extend to 2031, up from 2030. The company reported Q4 fiscal 2027 revenue of $54.2 billion, up from $41.5 billion last quarter and $11.3 billion year-over-year. Micron projects $61.5 billion in revenue for the next quarter, citing strong AI-driven demand and supply constraints.